Sort
35,931 grants matching “parkinsons”
Development of a first-in-class therapeutic for producing 'on-demand' voiding
$1,001,467Karl B Thor · Dignify Therapeutics, Llc · R44 · FY2018 · DK
Microfluidic cell squeezing platform for the transdifferentiation of somatic cells for efficient generation of a cell replacement therapy for Parkinsons Disease
$1,001,356Devin Bridgen · Sqz Biotechnologies Company, Inc. · R44 · FY2022 · GM
Neuropathology, Biomarker & Genetics Core C
$1,001,000John Q. Trojanowski · University Of Pennsylvania · U19 · FY2022 · AG
Center for Visual and Cognitive Neuroscience
$1,000,722Mark E. Mc Court · North Dakota State University · P30 · FY2017 · GM
OREGON ALZHEIMER DISEASE CENTER
$1,000,676Oregon Health And Science University · P30 · FY2000 · AG
Derivation of human pluripotent stem cells using small molecules
$1,000,000Yanhong Shi · Beckman Research Institute/City Of Hope · RC1 · FY2010 · NS
Generation of Induced Pluripotent Stem Cells with Novel Small Molecule Regulator
$1,000,000Young-Sup Yoon · Emory University · RC1 · FY2010 · GM
CRCNS Research Proposal: Modeling neural dynamics of naturalistic movements across contexts
$1,000,000Maryam Shanechi · University Of Southern California · · FY2021 · CSE
The Laboratory of Stem Cell Biology
$1,000,000Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2011 · AR
ORGANOCHLORINES AND METALS IN NEW YORK AND THE HUDSON
$1,000,000Mount Sinai School Of Medicine Of Nyu · P42 · FY2001 · ES
NSF Engines Development Award: Advancing neuroscience technologies to improve cognitive wellness (MO, IL)
$1,000,000Eric Leuthardt · Washington University · · FY2023 · TIP
Bridging Interventional Development Gaps (BrIDGs)
$1,000,000Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Parkinson's Disease Data Organizing Center
$1,000,000University Of Rochester · U01 · FY2004 · NS
2020 Waterman Award
$1,000,000Emily Balskus · Harvard University · · FY2020 · MPS
BLOOD-BASED EXOSOMAL A-SYNUCLEIN AGGREGATES AS A QUANTIFIABLE BIOMARKER OF PARKINSON'S DISEASE. NEW AWARD.
$1,000,000University Of Georgia Research Foundation, Inc. · · FY2020 · Defense Health Agency
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases
$1,000,000Rosh Chandraratna · Io Therapeutics, Inc. · R44 · FY2017 · AI
SBIR Phase II: An ultra-compact, remotely programmable chemical analyzer utilizing a novel ion trap mass spectrometer
$1,000,000Wade Rellergert · Ionicscale Llc · · FY2024 · TIP
IMPACT OF TAU PROTEIN DEPOSITION IN PARKINSON'S DISEASE.
$999,992The General Hospital Corporation · · FY2018 · Department of the Army
ACCELERATION OF NEUROPROTECTIVE AGENTS/THERAPEUTIC DEVELOPMENT AND OPTIMIZATION
$999,986Catherine E Price · Research Triangle Institute · N01 · FY2010 · NS
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
$999,982Sean Reineke · Aromha, Inc. · R42 · FY2021 · AG
A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds
$999,954Spiros Kambourakis · Cellibre Inc · R44 · FY2025 · AT
A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds
$999,954Spiros Kambourakis · Cellibre Inc · R44 · FY2024 · AT
Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
$999,922Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2022 · AG
Center for Visual and Cognitive Neuroscience
$999,869Mark E. Mc Court · North Dakota State University · P30 · FY2019 · GM
USP19 AS A NOVEL THERAPEUTIC TARGET FOR IMPEDING PROPAGATION AND SECRETION OF TAU IN PARKINSON'S DISEASE
$999,531The Research Institute Of The Mcgill University Health Centre · · FY2018 · Department of the Army